循环心力衰竭 SCIE

期刊简介预计审稿时间： 较慢,6-12周

Circulation: Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance. As a primarily clinical journal, few basic and preclinical studies are ultimately published. Those that will be considered are novel, and significantly and directly advance the field of heart failure. The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models. Less than 15% of submitted articles are ultimately published. Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.

《循环：心力衰竭》杂志考虑发表与心力衰竭、机械循环支持和心脏移植科学和医学相关的内容，包括对人类进行的研究或对人类数据的分析，以及具有直接临床相关性或相关性的临床前研究。作为一本主要针对临床的杂志，最终发表的基础研究和临床前研究很少。那些将被考虑的研究都是新颖的，并且对心力衰竭领域有重大而直接的推动作用。编辑们对与心力衰竭直接相关的基础科学研究特别感兴趣，这些研究信息量大，可转化为人类疾病，并在脊椎动物模型中进行。提交的文章中，只有不到 15% 最终得以发表。不直接涉及心力衰竭或心力衰竭治疗的研究将不予考虑，包括在没有心力衰竭底物的情况下研究心肌梗死、再灌注损伤或心律失常的机制。

《Circulation-heart Failure》(循环心力衰竭)编辑部通讯方式为LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。